News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
401,850 Results
Type
Article (47419)
Company Profile (82)
Press Release (354349)
Multimedia
Podcasts (18)
Webinars (10)
Section
Business (113833)
Career Advice (1299)
Deals (15771)
Drug Delivery (44)
Drug Development (50810)
Employer Resources (92)
FDA (7941)
Job Trends (8889)
News (188013)
Policy (14688)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2605)
Academic (1)
Accelerated approval (4)
Adcomms (8)
Allergies (47)
Alliances (33084)
ALS (62)
Alzheimer's disease (1133)
Antibody-drug conjugate (ADC) (69)
Approvals (7987)
Artificial intelligence (167)
Autoimmune disease (11)
Automation (6)
Bankruptcy (88)
Best Places to Work (7071)
BIOSECURE Act (10)
Biosimilars (27)
Biotechnology (54)
Bladder cancer (38)
Brain cancer (21)
Breast cancer (176)
Cancer (1495)
Cardiovascular disease (98)
Career advice (1084)
Career pathing (20)
CAR-T (102)
Cell therapy (266)
Cervical cancer (10)
Clinical research (39942)
Collaboration (610)
Compensation (69)
Complete response letters (6)
COVID-19 (1869)
CRISPR (30)
C-suite (121)
Cystic fibrosis (64)
Data (1492)
Decentralized trials (2)
Denatured (7)
Depression (28)
Diabetes (142)
Diagnostics (3760)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (24)
Drug discovery (94)
Drug pricing (47)
Drug shortages (6)
Duchenne muscular dystrophy (46)
Earnings (42370)
Editorial (20)
Employer branding (14)
Employer resources (80)
Events (49202)
Executive appointments (410)
FDA (8627)
Featured Employer (22)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (458)
Gene editing (64)
Generative AI (14)
Gene therapy (187)
GLP-1 (406)
Government (2284)
Grass and pollen (2)
Guidances (31)
Healthcare (10790)
Huntington's disease (10)
IgA nephropathy (19)
Immunology and inflammation (55)
Indications (18)
Infectious disease (1957)
Inflammatory bowel disease (87)
Inflation Reduction Act (4)
Influenza (38)
Intellectual property (56)
Interviews (261)
IPO (7593)
IRA (26)
Job creations (2130)
Job search strategy (937)
Kidney cancer (10)
Labor market (21)
Layoffs (247)
Leadership (8)
Legal (2482)
Liver cancer (35)
Lung cancer (209)
Lymphoma (103)
Machine learning (4)
Management (28)
Manufacturing (155)
MASH (47)
Medical device (5865)
Medtech (5867)
Mergers & acquisitions (8494)
Metabolic disorders (344)
Multiple sclerosis (50)
NASH (12)
Neurodegenerative disease (50)
Neuropsychiatric disorders (10)
Neuroscience (1475)
NextGen: Class of 2025 (3321)
Non-profit (3579)
Northern California (1420)
Now hiring (23)
Obesity (156)
Opinion (137)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (50)
Parkinson's disease (101)
Partnered (16)
Patents (117)
Patient recruitment (62)
Peanut (26)
People (32605)
Pharmaceutical (20)
Pharmacy benefit managers (4)
Phase I (12403)
Phase II (17019)
Phase III (13595)
Pipeline (865)
Policy (73)
Postmarket research (1892)
Preclinical (6753)
Press Release (65)
Prostate cancer (65)
Psychedelics (20)
Radiopharmaceuticals (161)
Rare diseases (206)
Real estate (3695)
Recruiting (35)
Regulatory (11074)
Reports (28)
Research institute (2503)
Resumes & cover letters (186)
Rett syndrome (1)
RNA editing (1)
RSV (21)
Schizophrenia (48)
Series A (69)
Series B (37)
Service/supplier (10)
Sickle cell disease (35)
Southern California (1248)
Special edition (12)
Spinal muscular atrophy (103)
Sponsored (21)
Startups (2160)
Stomach cancer (4)
Supply chain (30)
Tariffs (10)
The Weekly (11)
United States (12551)
Vaccines (461)
Venture capitalists (12)
Weight loss (83)
Women's health (14)
Worklife (8)
Date
Today (62)
Last 7 days (262)
Last 30 days (1350)
Last 365 days (19450)
2025 (5431)
2024 (20773)
2023 (24069)
2022 (33695)
2021 (35442)
2020 (32496)
2019 (26554)
2018 (19982)
2017 (19211)
2016 (19111)
2015 (22704)
2014 (17080)
2013 (15139)
2012 (15077)
2011 (15713)
2010 (14570)
Location
Africa (540)
Alabama (43)
Alaska (3)
Arizona (87)
Arkansas (4)
Asia (24691)
Australia (4708)
California (3210)
Canada (1165)
China (321)
Colorado (144)
Connecticut (153)
Delaware (79)
Europe (58673)
Florida (523)
Georgia (116)
Idaho (21)
Illinois (267)
India (22)
Indiana (186)
Iowa (6)
Japan (122)
Kansas (45)
Kentucky (11)
Louisiana (4)
Maine (19)
Maryland (478)
Massachusetts (2356)
Michigan (136)
Minnesota (160)
Mississippi (1)
Missouri (48)
Montana (16)
Nebraska (10)
Nevada (23)
New Hampshire (23)
New Jersey (1099)
New Mexico (26)
New York (1072)
North Carolina (601)
North Dakota (5)
Northern California (1420)
Ohio (117)
Oklahoma (6)
Oregon (13)
Pennsylvania (669)
Puerto Rico (2)
Rhode Island (17)
South America (592)
South Carolina (9)
Southern California (1248)
Tennessee (43)
Texas (498)
Utah (84)
Virginia (85)
Washington D.C. (44)
Washington State (359)
West Virginia (1)
Wisconsin (31)
401,850 Results for "frenova renal research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
Press Releases
National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma
March 31, 2025
·
10 min read
Press Releases
MultiOmic Health and Alloy Therapeutics Collaborate to Discover and Develop Renal Tissue-Targeting Drugs
April 2, 2025
·
4 min read
Drug Development
Saghmos Therapeutics Announces Collaboration with Duke Clinical Research Institute to Optimize Phase 3 Cardio-Renal Metabolic Study
Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company, announced it will partner with the Duke Clinical Research Institute (DCRI) to optimize all aspects of and plan the operationalization of Saghmos’ Phase 3 study for its cardio-renal metabolic modulator ST-62516.
April 17, 2024
·
4 min read
Aiosyn Introduces Kidney AI Platform to Revolutionize Renal Disease Research
Aiosyn, a medical software company specializing in AI-powered pathology solutions, has announced the release of an AI kidney suite designed to advance research in the field of renal disease.
September 18, 2023
·
2 min read
Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024
Fresenius Medical Care today announced the presentation of nearly 40 company-affiliated research abstracts at the 61st European Renal Association (ERA) Congress, taking place May 23-26, 2024, in Stockholm, Sweden and virtually.
May 21, 2024
·
5 min read
Press Releases
Innovent and HUTCHMED Jointly Announce that the FRUSICA-2 Phase 2/3 Study of Sintilimab and Fruquintinib Combination Has Met Its Primary Endpoint in Advanced Renal Cell Carcinoma in China
March 19, 2025
·
13 min read
Press Releases
HUTCHMED and Innovent Jointly Announce that the FRUSICA-2 Phase II/III Study of Fruquintinib and Sintilimab Combination Has Met its Primary Endpoint in Advanced Renal Cell Carcinoma in China
March 19, 2025
·
14 min read
Press Releases
FDA Grants IDE Approval for the Pivotal Trial of the JuxtaFlow® Renal Assist Device (RAD)
December 19, 2024
·
4 min read
Press Releases
Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System
January 14, 2025
·
6 min read
1 of 40,185
Next
